Clinical Trial Update: CLARA: Somatic and Germline Mechanisms That Impact Renal Cancer Immunotherapy [Phase 2]

View source ↗

Summary

Clinical trial update for the Phase 2 study CLARA investigating somatic and germline factors that influence renal cancer immunotherapy response.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma Metastatic

Snippet

Sponsor: Hospital das Clínicas de Ribeirão Preto | Conditions: Renal Cancer Metastatic | Phase 2 | Status: ACTIVE_NOT_RECRUITING